CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.

Cell Stem Cell 2014 Mar;14(3):342-56

Surgical and Oncological Sciences, University of Palermo, 90127 Palermo, Italy. Electronic address:

Cancer stem cells drive tumor formation and metastasis, but how they acquire metastatic traits is not well understood. Here, we show that all colorectal cancer stem cells (CR-CSCs) express CD44v6, which is required for their migration and generation of metastatic tumors. CD44v6 expression is low in primary tumors but demarcated clonogenic CR-CSC populations. Cytokines hepatocyte growth factor (HGF), osteopontin (OPN), and stromal-derived factor 1α (SDF-1), secreted from tumor associated cells, increase CD44v6 expression in CR-CSCs by activating the Wnt/β-catenin pathway, which promotes migration and metastasis. CD44v6(-) progenitor cells do not give rise to metastatic lesions but, when treated with cytokines, acquire CD44v6 expression and metastatic capacity. Importantly, phosphatidylinositol 3-kinase (PI3K) inhibition selectively killed CD44v6 CR-CSCs and reduced metastatic growth. In patient cohorts, low levels of CD44v6 predict increased probability of survival. Thus, the metastatic process in colorectal cancer is initiated by CSCs through the expression of CD44v6, which is both a functional biomarker and therapeutic target.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19345909140001
Publisher Site
http://dx.doi.org/10.1016/j.stem.2014.01.009DOI Listing
March 2014
30 Reads

Publication Analysis

Top Keywords

cd44v6 expression
12
stem cells
12
cancer stem
12
colorectal cancer
8
cd44v6
8
metastatic
6
cells
5
cancer
5
low levels
4
secreted tumor
4
sdf-1 secreted
4
tumor associated
4
cd44v6 predict
4
cr-cscs activating
4
expression cr-cscs
4
levels cd44v6
4
increase cd44v6
4
1α sdf-1
4
cells increase
4
associated cells
4

Similar Publications